|
CN111388482A
|
|
Application of polaprezinc in preparation of medicine for enhancing sensitivity of helicobacter pylori to antibiotics
|
|
CN110917201A
|
|
Application of polaprezinc in preparation of medicine for treating atrophic gastritis with gastric mucosal epithelial dysplasia
|
|
CN110974779A
|
|
Poly-zinc-based rectal gel and preparation method and application thereof
|
|
CN110974833A
|
|
Medical application of medicine for treating atrophic gastritis by applying polaprezinc alone
|
|
CN110279700A
|
|
Application of the Polaprezinc in preparation treatment liver source property alimentary canal mucous membrane damage medicine
|
|
CN110237228A
|
|
Polaprezinc prevents the postoperative application taken in the drug of ulcer substrate protrusion caused by PPI of scope ESD in preparation
|
|
CN108125963A
|
|
Polaprezinc rectally preparation and the application for preparing ulcerative colitis drug
|
|
CN108175849A
|
|
Polaprezinc oral preparation and the application in ulcerative colitis drug is prepared
|
|
CN106511351A
|
|
Application of polaprezinc in preparing medicine for eradicating helicobacter pylori
|
|
CN106491553A
|
|
A kind of new synthesis process of dabigatran etexilate methanesulfonate
|
|
CN106511277A
|
|
Polaprezinc granule and preparation method thereof
|
|
CN106562976A
|
|
Application of polaprezinc in preparing medicines for treating colon cancer
|
|
CN110215510A
|
|
Application of the Polaprezinc in preparation treatment or mitigation caused by radiotherapy and chemotherapy injury to alimentary tract drug
|
|
CN103524528A
|
|
Improved preparation method of II-type clopidogrel hydrogen sulfate crystal
|
|
CN102206864A
|
|
Agomelatine monocrystal with agomelatine VI crystal form, agomelatine mixed crystal with the agomelatine VI crystal form and preparation methods
|
|
CN102241669A
|
|
Preparation method of fasudil hydrochloride
|
